About Hemcheck
Hemcheck is a company based in Karlstad (Sweden) founded in 2010. Hemcheck has raised $447.63 thousand across 4 funding rounds from investors including Almi Invest, Alfvén & Didrikson and Innovationsbron. Hemcheck offers products and services including Helge Concept, s-Test, bgs-Test, and v-Test. Hemcheck operates in a competitive market with competitors including Epocal, Daxor, Cellmic, Essenlix and Chipcare, among others.
- Headquarter Karlstad, Sweden
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hemcheck Sweden Ab
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$447.63 K (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
Almi Invest
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Hemcheck
Hemcheck offers a comprehensive portfolio of products and services, including Helge Concept, s-Test, bgs-Test, and v-Test.
Integrated system for detecting hemolysed blood samples at point of care
Disposable test for blood samples in blood gas syringes
Test for analyzing blood gas samples for hemolysis
Test for blood samples in vacuum tubes to detect hemolysis
Funding Insights of Hemcheck
Hemcheck has successfully raised a total of $447.63K across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Hemcheck
Hemcheck has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Almi Invest, Alfvén & Didrikson and Innovationsbron.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by corporate-backed Almi Invest.
|
Locked | Locked | Locked | |
|
Early & mid-stage life sciences and tech focused VC firm investing primarily in Sweden
|
Locked | Locked | Locked | |
|
Innovationsbron is operated as a platform for sharing innovation insights.
|
Locked | Locked | Locked |
Investor details for Hemcheck
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Hemcheck
Investment portfolio details for Hemcheck
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Hemcheck
Detailed financials for Hemcheck
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hemcheck Comparisons
Peer comparison for Hemcheck
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Hemcheck
Hemcheck operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Epocal, Daxor, Cellmic, Essenlix and Chipcare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biochips and solid-state diagnostic devices for blood testing are developed.
|
|
| Locked | Locked | Locked |
Blood volume analyzers are developed by Daxor for diagnostic applications.
|
|
| Locked | Locked | Locked |
Rapid test readers are developed for chromatographic and fluorescent assays.
|
|
| Locked | Locked | Locked |
Mobile health self-test platform is provided using nanotechnology and AI.
|
|
| Locked | Locked | Locked |
Develops a hand-held blood test device from a single drop of blood.
|
Detailed competitors of Hemcheck
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hemcheck
Complete news archive for Hemcheck
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemcheck
Hemcheck was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Hemcheck is headquartered in Karlstad, Sweden. It is registered at Karlstad, Varmland, Sweden.
Joen Averstad is the current CEO of Hemcheck.
Hemcheck is a funded company, having raised a total of $447.63K across 4 funding rounds to date.
Hemcheck was founded in 2010 in Karlstad, Sweden, and operates in the medical device sector. Blood sample integrity is assessed through its flagship product, which includes disposable s-Test for blood gas syringes and v-Test for test tubes. Hemolysis in samples is detected to prevent non-analyzed results, supporting laboratory and clinical workflows across healthcare settings.
Hemcheck's top competitors include Daxor, Pathshodh Healthcare and Cellmic.
Hemcheck offers Helge Concept, s-Test, bgs-Test, and v-Test.
Hemcheck has 4 investors. Key investors include Almi Invest, Alfvén & Didrikson, Innovationsbron, and Sting Bioeconomy.